JPWO2023057766A5 - - Google Patents

Info

Publication number
JPWO2023057766A5
JPWO2023057766A5 JP2024521254A JP2024521254A JPWO2023057766A5 JP WO2023057766 A5 JPWO2023057766 A5 JP WO2023057766A5 JP 2024521254 A JP2024521254 A JP 2024521254A JP 2024521254 A JP2024521254 A JP 2024521254A JP WO2023057766 A5 JPWO2023057766 A5 JP WO2023057766A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
flu
acid residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024521254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537250A5 (https=
JP2024537250A (ja
Publication date
Priority claimed from GBGB2114328.4A external-priority patent/GB202114328D0/en
Priority claimed from GBGB2208070.9A external-priority patent/GB202208070D0/en
Priority claimed from GBGB2213958.8A external-priority patent/GB202213958D0/en
Application filed filed Critical
Priority claimed from PCT/GB2022/052534 external-priority patent/WO2023057766A1/en
Publication of JP2024537250A publication Critical patent/JP2024537250A/ja
Publication of JP2024537250A5 publication Critical patent/JP2024537250A5/ja
Publication of JPWO2023057766A5 publication Critical patent/JPWO2023057766A5/ja
Pending legal-status Critical Current

Links

JP2024521254A 2021-10-06 2022-10-06 インフルエンザワクチン Pending JP2024537250A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB2114328.4 2021-10-06
GBGB2114328.4A GB202114328D0 (en) 2021-10-06 2021-10-06 Influenza vaccines
GBGB2208070.9A GB202208070D0 (en) 2022-05-31 2022-05-31 Influenza vaccines
GB2208070.9 2022-05-31
GBGB2213958.8A GB202213958D0 (en) 2022-09-23 2022-09-23 Influenza vaccines
GB2213958.8 2022-09-23
PCT/GB2022/052534 WO2023057766A1 (en) 2021-10-06 2022-10-06 Influenza vaccines

Publications (3)

Publication Number Publication Date
JP2024537250A JP2024537250A (ja) 2024-10-10
JP2024537250A5 JP2024537250A5 (https=) 2025-10-15
JPWO2023057766A5 true JPWO2023057766A5 (https=) 2025-10-15

Family

ID=83692952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024521254A Pending JP2024537250A (ja) 2021-10-06 2022-10-06 インフルエンザワクチン

Country Status (6)

Country Link
US (1) US20240408190A1 (https=)
EP (1) EP4412644A1 (https=)
JP (1) JP2024537250A (https=)
AU (1) AU2022360009A1 (https=)
CA (1) CA3234653A1 (https=)
WO (1) WO2023057766A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202004825D0 (en) * 2020-04-01 2020-05-13 Diosynvax Ltd Influenza vaccines
GB202315888D0 (en) * 2023-10-17 2023-11-29 Diosynvax Ltd Influenza vaccines
WO2026018213A1 (en) * 2024-07-18 2026-01-22 Vaxthera Sas A broadly protective mosaic vaccine against highly pathogenic avian influenza viruses
WO2026074282A1 (en) * 2024-10-01 2026-04-09 Diosynvax Ltd. Influenza vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR083533A1 (es) * 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
WO2013075266A1 (en) * 2011-11-23 2013-05-30 Vacdiagn Biotechnology Co., Ltd. Immune methods against influenza viruses and combinatorial vaccines thereof
EP2814837B1 (en) * 2012-02-13 2017-11-29 University of Pittsburgh - Of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for human and avian h5n1 influenza
TW201729835A (zh) 2015-10-22 2017-09-01 現代公司 呼吸道病毒疫苗
EP3852799A4 (en) * 2018-09-21 2022-10-05 Board of Regents of the University of Nebraska METHODS FOR THE PRODUCTION AND USE OF UNIVERSAL CENTRALIZED FLU VACCINE GENES

Similar Documents

Publication Publication Date Title
US11229694B2 (en) Vaccine against RSV
JP2023018073A5 (https=)
JP2025184979A5 (https=)
JP7317047B2 (ja) インフルエンザウイルスワクチン及びその使用
JP2024180560A5 (https=)
JP2020530765A5 (https=)
CN109678937B (zh) H3n2亚型流感病毒血凝素蛋白的突变体及其应用
TWI396741B (zh) 非洲綠猴腎細胞培養之流感病毒及疫苗
JP2024537250A (ja) インフルエンザワクチン
KR20220057578A (ko) 인플루엔자 바이러스 백신 및 이의 용도
US10548973B2 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
JPH0789992A (ja) 免疫原性人工ポリペプチド
JP2020509770A5 (https=)
CA3053591C (en) Polypeptide carrier for presenting target polypeptide and uses thereof
JP2018533908A5 (https=)
JPWO2023057766A5 (https=)
WO1993015763A1 (en) Vaccinal polypeptides
RU2358981C2 (ru) Универсальная вакцина против вируса гриппа птиц
US6261799B1 (en) Expression cassettes encoding soluble, non-cleavable, chimeric HIV-1 GP160 variants, their methods of construction, and methods for the production of GP160 variants
JP6373601B2 (ja) アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド
JPWO2021198701A5 (https=)
CN116888139A (zh) 诱导高水平i型干扰素的新型复制缺陷型甲型流感病毒
Hara et al. Presence of a hypervariable region within the hr2 domain of the host range determining sequences of the envelope protein gp85 (SU) of subgroup-A avian sarcoma-leukosis viruses
AU2024225919A1 (en) Multicistronic vaccine and methods for producing and using the same
Laver et al. Summary of a Meeting on Structure and Variation in Influenza Viruses